Advertisement

Virchows Archiv

, Volume 472, Issue 1, pp 29–41 | Cite as

Esophagitis unrelated to reflux disease: current status and emerging diagnostic challenges

  • Melanie E. Johncilla
  • Amitabh Srivastava
Invited Annual Review Issue

Abstract

There has been much progress in our understanding of esophageal inflammatory disorders in the past few years. This is particularly true about esophageal eosinophilia and PPI responsiveness, lymphocytic esophagitis and motility disorders, and short-term risk of neoplasia in esophageal leukoplakia. The current review will summarize esophageal injury patterns that primarily occur due to non-reflux causes, with a focus on usual pitfalls in biopsy diagnosis and recent advances in our knowledge of the more common forms of esophagitis.

Keywords

Esophagus Inflammation Histopathology Eosinophilic esophagitis Lymphocytic esophagitis Leukoplakia 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Reference

  1. 1.
    Wishingrad M (1999) Sexually transmitted esophagitis: primary herpes simplex virus type 2 infection in a healthy man. Gastrointest Endosc 50(6):845–846CrossRefPubMedGoogle Scholar
  2. 2.
    Maiorana A et al (2003) Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients. Hum Pathol 34(12):1331–1336CrossRefPubMedGoogle Scholar
  3. 3.
    Chen Z, Scudiere JR, Montgomery E (2009) Medication-induced upper gastrointestinal tract injury. J Clin Pathol 62(2):113–119CrossRefPubMedGoogle Scholar
  4. 4.
    Parfitt JR, Driman DK (2007) Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol 38(4):527–536CrossRefPubMedGoogle Scholar
  5. 5.
    Abraham SC, Yardley JH, Wu TT (1999) Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity. Am J Surg Pathol 23(10):1241–1247CrossRefPubMedGoogle Scholar
  6. 6.
    Lee FD (1994) Drug-related pathological lesions of the intestinal tract. Histopathology 25(4):303–308CrossRefPubMedGoogle Scholar
  7. 7.
    Boyce HW Jr (1998) Drug-induced esophageal damage: diseases of medical progress. Gastrointest Endosc 47(6):547–550CrossRefPubMedGoogle Scholar
  8. 8.
    Graham DY (2002) What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci 47(8):1665–1678CrossRefPubMedGoogle Scholar
  9. 9.
    de Groen PC et al (1996) Esophagitis associated with the use of alendronate. N Engl J Med 335(14):1016–1021CrossRefPubMedGoogle Scholar
  10. 10.
    Abraham SC et al (1999) Alendronate-associated esophageal injury: pathologic and endoscopic features. Mod Pathol 12(12):1152–1157PubMedGoogle Scholar
  11. 11.
    Millar AJ, Cox SG (2015) Caustic injury of the oesophagus. Pediatr Surg Int 31(2):111–121CrossRefPubMedGoogle Scholar
  12. 12.
    Uygun I et al (2012) Clinico-epidemiological study of caustic substance ingestion accidents in children in Anatolia: the DROOL score as a new prognostic tool. Acta Chir Belg 112(5):346–354CrossRefPubMedGoogle Scholar
  13. 13.
    Kay M, Wyllie R (2009) Caustic ingestions in children. Curr Opin Pediatr 21(5):651–654CrossRefPubMedGoogle Scholar
  14. 14.
    Riffat F, Cheng A (2009) Pediatric caustic ingestion: 50 consecutive cases and a review of the literature. Dis Esophagus 22(1):89–94CrossRefPubMedGoogle Scholar
  15. 15.
    Purdy JK, Appelman HD, McKenna BJ (2012) Sloughing esophagitis is associated with chronic debilitation and medications that injure the esophageal mucosa. Mod Pathol 25(5):767–775CrossRefPubMedGoogle Scholar
  16. 16.
    Carmack SW et al (2009) Esophagitis dissecans superficialis (“sloughing esophagitis”): a clinicopathologic study of 12 cases. Am J Surg Pathol 33(12):1789–1794CrossRefPubMedGoogle Scholar
  17. 17.
    Trabulo D et al (2015) Esophageal stenosis with sloughing esophagitis: a curious manifestation of graft-vs-host disease. World J Gastroenterol 21(30):9217–9222CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Baum S, Sakka N, Artsi O et al (2014 Apr-May) Diagnosis and classification of autoimmune blistering diseases. Autoimmun Rev 13(4–5):482–489CrossRefPubMedGoogle Scholar
  19. 19.
    Goldberg NS, Weiss SS (1989 Nov) Pemphigus vulgaris of the esophagus in women. J Am Acad Dermatol 21(5 Pt 2):1115–1118CrossRefPubMedGoogle Scholar
  20. 20.
    Ahmadi B, DePasquale JR (2003) Esophageal bullous pemphigoid. Am J Gastroenterol 98:S214–S215CrossRefGoogle Scholar
  21. 21.
    Chang S, Park SJ, Kim SW et al (2014 Sep) Esophageal involvement of Pemphigus vulgaris associated with upper gastrointestinal bleeding. Clin Endosc 47(5):452–454CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kia L, Hirano I (2015) Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies. Nat Rev Gastroenterol Hepatol 12(7):379–386CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Liacouras CA et al (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 128(1):3–20 e6 quiz 21-2CrossRefPubMedGoogle Scholar
  24. 24.
    Straumann A et al (2012) Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 67(4):477–490CrossRefPubMedGoogle Scholar
  25. 25.
    Furuta GT et al (2007) Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133(4):1342–1363CrossRefPubMedGoogle Scholar
  26. 26.
    Molina-Infante J et al (2011) Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 9(2):110–117CrossRefPubMedGoogle Scholar
  27. 27.
    Wen T et al (2015) Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol 135(1):187–197CrossRefPubMedGoogle Scholar
  28. 28.
    Dellon ES et al (2013) Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 108(12):1854–1860CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Moawad FJ et al (2013) Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol 108(3):366–372CrossRefPubMedGoogle Scholar
  30. 30.
    Molina-Infante J et al (2014) Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther 40(8):955–965CrossRefPubMedGoogle Scholar
  31. 31.
    Iwakura N et al (2015) Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther 41(8):776–784CrossRefPubMedGoogle Scholar
  32. 32.
    Warners MJ et al (2015) PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs. Eur J Gastroenterol Hepatol 27(5):506–511CrossRefPubMedGoogle Scholar
  33. 33.
    Hirano I et al (2013) Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 62(4):489–495CrossRefPubMedGoogle Scholar
  34. 34.
    Collins MH (2014) Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Gastroenterol Clin N Am 43(2):257–268CrossRefGoogle Scholar
  35. 35.
    Sayej WN et al (2009) Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 49(4):393–399CrossRefPubMedGoogle Scholar
  36. 36.
    Isomoto H et al (2004) Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux. Am J Gastroenterol 99(6):1063–1068CrossRefPubMedGoogle Scholar
  37. 37.
    Wen T et al (2013) Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology 145(6):1289–1299CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Peterson KA et al (2010) Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 55(5):1313–1319CrossRefPubMedGoogle Scholar
  39. 39.
    Lucendo AJ, Arias A, and Molina-Infante J (2016) Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol 14(1): p. 13-22 e1CrossRefPubMedGoogle Scholar
  40. 40.
    Rubio CA, Sjodahl K, Lagergren J (2006) Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol 125(3):432–437CrossRefPubMedGoogle Scholar
  41. 41.
    Haque S, Genta RM (2012) Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut 61(8):1108–1114CrossRefPubMedGoogle Scholar
  42. 42.
    Purdy JK et al (2008) Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol 130(4):508–513CrossRefPubMedGoogle Scholar
  43. 43.
    Xue Y et al (2015) Lymphocytic esophagitis with CD4 T-cell-predominant intraepithelial lymphocytes and primary esophageal motility abnormalities: a potential novel clinicopathologic entity. Am J Surg Pathol 39(11):1558–1567CrossRefPubMedGoogle Scholar
  44. 44.
    Rubio CA, Ichiya T, Schmidt PT (2017 Mar) Lymphocytic oesophagitis, eosinophilic oesophagitis and compound lymphocytic-eosinophilic oesophagitis I: histological and immunohistochemical findings. J Clin Pathol 70(3):208–216CrossRefPubMedGoogle Scholar
  45. 45.
    Ebach DR et al (2011) Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn’s disease. Inflamm Bowel Dis 17(1):45–49CrossRefPubMedGoogle Scholar
  46. 46.
    Sutton LM et al (2014) Lymphocytic esophagitis in children. Inflamm Bowel Dis 20(8):1324–1328CrossRefPubMedGoogle Scholar
  47. 47.
    Cohen S et al (2012) Lymphocytic esophagitis: a diagnosis of increasing frequency. J Clin Gastroenterol 46(10):828–832CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Basseri B et al (2013) Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel disease. Gastroenterol Hepatol (N Y) 9(8):505–511Google Scholar
  49. 49.
    Putra J et al (2016) Lymphocytic esophagitis in nonachalasia primary esophageal motility disorders: improved criteria, prevalence, strength of association, and natural history. Am J Surg Pathol 40(12):1679–1685CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Zerbib F, Roman S (2015) Current therapeutic options for esophageal motor disorders as defined by the Chicago Classification. J Clin Gastroenterol 49(6):451–460PubMedGoogle Scholar
  51. 51.
    Scully C, el-Kom M (1985) Lichen planus: review and update on pathogenesis. J Oral Pathol 14(6):431–458CrossRefPubMedGoogle Scholar
  52. 52.
    Lund WS (1976) Treatment of superficial lesions of the mouth and pharynx. J Laryngol Otol 90(1):105–112CrossRefPubMedGoogle Scholar
  53. 53.
    Abraham SC et al (2000) Esophageal lichen planus: case report and review of the literature. Am J Surg Pathol 24(12):1678–1682CrossRefPubMedGoogle Scholar
  54. 54.
    Chryssostalis A et al (2008) Esophageal lichen planus: a series of eight cases including a patient with esophageal verrucous carcinoma. A case series. Endoscopy 40(9):764–768CrossRefPubMedGoogle Scholar
  55. 55.
    Quispel R et al (2009) High prevalence of esophageal involvement in lichen planus: a study using magnification chromoendoscopy. Endoscopy 41(3):187–193CrossRefPubMedGoogle Scholar
  56. 56.
    Salaria SN et al (2013) Lichenoid esophagitis: clinicopathologic overlap with established esophageal lichen planus. Am J Surg Pathol 37(12):1889–1894CrossRefPubMedGoogle Scholar
  57. 57.
    Katzka DA et al (2010) Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol 8(9):777–782CrossRefPubMedGoogle Scholar
  58. 58.
    Silverman S Jr, Gorsky M, Lozada-Nur F (1985) A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 60(1):30–34CrossRefPubMedGoogle Scholar
  59. 59.
    Silverman S Jr et al (1991) A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 72(6):665–670CrossRefPubMedGoogle Scholar
  60. 60.
    Briggs GW (1961) Amyloidosis. Ann Intern Med 55:943–957CrossRefPubMedGoogle Scholar
  61. 61.
    Tada S et al (1990) Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc 36(1):10–14CrossRefPubMedGoogle Scholar
  62. 62.
    Costigan DJ, Clouse RE (1983) Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig Dis Sci 28(8):763–765CrossRefPubMedGoogle Scholar
  63. 63.
    Lazaraki G et al (2009) A rare case of multiple myeloma initially presenting with pseudoachalasia. Dis Esophagus 22(6):E21–E24CrossRefPubMedGoogle Scholar
  64. 64.
    Rubinow A et al (1983) Esophageal manometry in systemic amyloidosis. A study of 30 patients. Am J Med 75(6):951–956CrossRefPubMedGoogle Scholar
  65. 65.
    Ip S et al (2016) Sensitivities of biopsy sites in the endoscopic evaluation of graft-versus-host disease: retrospective review from a tertiary center. Dig Dis Sci 61(8):2351–2356CrossRefPubMedGoogle Scholar
  66. 66.
    Novak JM et al (1979) Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol 1(1):9–39CrossRefPubMedGoogle Scholar
  67. 67.
    Seaman WB, Ackerman LV (1957) The effect of radiation on the esophagus; a clinical and histologic study of the effects produced by the betatron. Radiology 68(4):534–541CrossRefPubMedGoogle Scholar
  68. 68.
    Taggart MW et al (2013) Oesophageal hyperkeratosis: clinicopathological associations. Histopathology 63(4):463–473PubMedGoogle Scholar
  69. 69.
    Kaye MD (1987) Esophageal leukoplakia. Gastrointest Endosc 33(3):254–259CrossRefPubMedGoogle Scholar
  70. 70.
    Singhi AD et al (2014) Esophageal leukoplakia or epidermoid metaplasia: a clinicopathological study of 18 patients. Mod Pathol 27(1):38–43CrossRefPubMedGoogle Scholar
  71. 71.
    Ezoe Y et al (2011) Epidermoid metaplasia of the esophagus: endoscopic feature and differential diagnosis. Hepato-Gastroenterology 58(107–108):809–813PubMedGoogle Scholar
  72. 72.
    Postlethwait RW, Musser AW (1974) Changes in the esophagus in 1,000 autopsy specimens. J Thorac Cardiovasc Surg 68(6):953–956PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  1. 1.Department of PathologyWeill Cornell Medical CollegeNew YorkUSA
  2. 2.Department of PathologyBrigham and Women’s HospitalBostonUSA

Personalised recommendations